16:00-18:00 -
[-]2007 World Congress
--->Organising Committees
--->Sponsors
--->Downloads
--->Important Dates
[-]Programme
--->Saturday
--->Sunday
--->Monday
--->Tuesday
--->Social Programme
[+]Travel & Location
--->Links
--->Contact
MONDAY, 10 SEPTEMBER, 2007 (Concurrent Sessions WFN & IHA)
Hall 1, Hall 4 and Meeting Room 1
16:00-18:00
Scientific Session III: Inflammatory and Metabolic Alterations in HD
Chairs:Sarah Tabrizi (London, UK), Raymond A.C. Roos (Leiden, The Netherlands)
16:00Peripheral Immune Dysfunction in HD Revealed by Proteomic Profiling
Edward J Wild (London, UK)
16:15A Peripheral Immune Response in Huntington’s Disease
Maria Björkqvist (Lund, Sweden)
16:30Neuroinflammation in Huntington’s Disease
Thomas Moeller (Seattle, USA)
16:45Microglial Signalling Pathways as Potential Therapeutic Target in HD
Paul Muchochwski (San Francisco, USA)
17:00PGC1-Alpha and Metabolic Derangement in HD
Al LaSpada (Seattle, USA)
17:25Hypothalamic Dysfunction in HD: What is the Evidence?
Åsa Petersén (Lund, Sweden)
17:40Hypothalamic Involvement in Huntington’s Disease
Marios Politis (London, UK)
17:50Hypocretin and Melanin-Concentrating Hormone in Patients with Huntington’s Disease
Ahmad Aziz (Leiden, The Netherlands)
Clinical Session III: Clinical Practice: Genetic Testing, Predicting Onset and Phenotype & Guidance for Care
Chairs:Claudia Downing (Cambridge, UK), Arvid Heiberg (Oslo, Norway), Jacek Zaremba (Warsaw, Poland)
16:00Factors Associated with the Decision to Pursue Genetic Testing in Individuals at Risk for Huntington´s Disease
Kimberly Quaid (Indianapolis, USA)
16:10Experiences of Genetic Discrimination are Common in Persons at Risk for Huntington´s Disease
Yvonne Bombard (Vancouver, Canada)
16:20Long-Term Consequences of Predictive Genetic Testing for Huntington’s Disease on Mental Health and Quality of Life
Claudia Licklederer (Freiburg, Germany)
16:30Estimating Decreased Risks for Huntington’s Disease without a Test
Reinier Timman (Leiden, The Netherlands)
16:40Huntington's Disease with 34 Trinucleotide Repeats?
Carsten Saft (Bochum, Germany)
16:50Quality Control in Genotyping and Intermediate Alleles
Oliver Quarrell (Sheffield, UK)
17:00Prospective Validation of CAG-Based Age of Diagnosis in Huntington’s Disease
Douglas R. Langbehn (Iowa, USA)
17:15Premorbid Aspects of Personality as Predictors of Huntington’s Disease Symptomatology
Lucienne van der Meer (Leiden, The Netherlands)
17:30A Guideline for Care for Huntington’s Disease
Sheila A Simpson (Aberdeen, UK)
17:45Terminal Symptoms and End-Of-Life Care in Nursing Home Residents with Huntington's Disease
Martha Nance (Minneapolis, USA)
IHA Session III
Chairs:Jillian Foster (Kirkcaldy, UK), Ann Jones (Claremont, Australia)
16:00Young Peoples Views of Growing up in a Family with HD
Karen Keenen, Catherine Martin (Scottish Huntington Association)
Reports of Support Systems in Member Countries
Rehabilitation in HD – an Experience from Italy
Stefano Maceroni, Paola Zinzi (Rome, Italy)
Illness Perceptions, Coping Mechanisms and Well Being of HD-Patients and their Partners
Lucienne van der Meer (Leiden, The Netherlands)

Back to Overview
8:30-10:3011:00-13:0014:00-15:3016:00-18:00